SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Nov 7, 2017

Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Nov. 7, 2017 · CIK: 0000890821 · Accession: 0001193805-17-003405

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-220499

Date
November 7, 2017
Author
Jeff Peterson
Form
CORRESP
Company
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)

Letter

November 7, 2017

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention:

Amanda Ravitz, Assistant Director

c/o Caleb French

Re: Ameri Holdings, Inc.

Registration Statement on Form S-1 (No. 333-220499)

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Act”), Northland Securities, Inc., as representative of the several underwriters, hereby joins Ameri Holdings, Inc. in requesting that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 3:00 p.m. Eastern time on Wednesday, November 8, 2017, or as soon thereafter as possible.

Pursuant to Rule 460 under the Act, we, as representative of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

This is to further advise you that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced Preliminary Prospectus.

Very truly yours,
Northland Securities, Inc.

Show Raw Text
CORRESP
1
filename1.htm

November 7, 2017

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

    Attention:

        Amanda Ravitz, Assistant Director

        c/o Caleb French

 Re:   Ameri Holdings, Inc.

Registration Statement on Form S-1 (No. 333-220499)

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act
of 1933, as amended (the “Act”), Northland Securities, Inc., as representative of the several underwriters, hereby
joins Ameri Holdings, Inc. in requesting that the effective date for the Registration Statement referred to above be accelerated
so that it will be declared effective at 3:00 p.m. Eastern time on Wednesday, November 8, 2017, or as soon thereafter as possible.

Pursuant to Rule 460 under the Act, we,
as representative of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer,
who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

This is to further advise you that the underwriters
have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection
with the above-referenced Preliminary Prospectus.

    Very truly yours,

    Northland Securities, Inc.

    By:
    /s/ Jeff Peterson

    Name: Jeff Peterson

    Title:   Managing Director

[Signature Page to Underwriters’
Acceleration Request]